Skip to main content
Fig. 52 | European Journal of Hybrid Imaging

Fig. 52

From: Non-FDG PET/CT in Diagnostic Oncology: a pictorial review

Fig. 52

68Ga-DOTA peptide, staging of NET lung primary, comparison with FDG. Clinical history: 65 y.o. man. Staging of a lung mass with FDG PET and biopsy indicated a moderately differentiated NET (grade 2, Ki67 8%). Consequently, the patient underwent a second PET using 68Ga-DOTANOC to stage the disease more accurately. PET/CT findings: increased focal uptake in FDG PET in the right lung, without any other findings (a MIP). 68Ga-DOTANOC showed intense uptake in the lung and in the thyroid due to a known De Quervain thyroiditis (b MIP)

Back to article page